Changes In Health Services Use After Receipt Of Medications For Opioid Use Disorder In A Statewide Correctional System

被引:12
作者
Howell, Benjamin A. [1 ,2 ]
Martin, Rosemarie A. [3 ]
Lebeau, Rebecca [4 ]
Truong, Ashley Q. [5 ]
Wang, Emily A. [1 ]
Rich, Josiah D. [6 ,7 ]
Clarke, Jennifer G. [8 ]
机构
[1] Yale Sch Med, Sect Gen Internal Med, New Haven, CT 06510 USA
[2] Yale Sch Med, SEICHE Ctr, New Haven, CT 06510 USA
[3] Brown Univ, Sch Publ Hlth, Dept Behav & Social Sci, Providence, RI USA
[4] Rhode Isl Execut Off Hlth & Human Serv, Cranston, RI USA
[5] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mental Hlth, Baltimore, MD USA
[6] Brown Univ, Med & Epidemiol, Div Infect Dis, Providence, RI 02912 USA
[7] Miriam Hosp, Ctr Prisoner Hlth & Human Rights, Providence, RI 02906 USA
[8] Rhode Isl Dept Correct, Cranston, RI USA
关键词
ECONOMIC BURDEN; ASSISTED TREATMENT; UNITED-STATES; OVERDOSE; MORTALITY; RELEASE; COSTS; ABUSE; RISK;
D O I
10.1377/hlthaff.2020.02156
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
To decrease opioid overdose mortality, prisons and jails in the US are increasingly offering medications for opioid use disorder (OUD) to incarcerated people. It is unknown how receipt of these medications in a correctional setting affects health services use after release. In this article we analyze changes in postrelease health care use after the implementation of a statewide medications for OUD program in the unified jail and prison system of the Rhode Island Department of Corrections. Using Medicaid claims data, we examined individual health care use in the community before and after receipt of medications for OUD while incarcerated. We found that inpatient admissions did not change, emergency department visits decreased, and both nonacute outpatient services and pharmacy claims increased after people received medications for OUD while incarcerated. There was no change in total health care costs paid by Medicaid. Our findings provide evidence that people's use of health care services paid for by Medicaid did not increase after they started medications for OUD in correctional settings. Given the frequent interaction of people with OUD with the criminal justice system, offering evidence-based treatment of OUD in correctional settings is an important opportunity to initiate addiction treatment.
引用
收藏
页码:1304 / 1311
页数:8
相关论文
共 50 条
  • [31] Drug court utilization of medications for opioid use disorder in high opioid mortality communities
    Marlowe, Douglas B.
    Theiss, David S.
    Ostlie, Erika M.
    Carnevale, John
    JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2022, 141
  • [32] Probation clients' barriers to access and use of opioid use disorder medications
    Reichert, Jessica
    Gleicher, Lily
    HEALTH & JUSTICE, 2019, 7 (01)
  • [33] Legal Authority for Emergency Medical Services to Increase Access to Buprenorphine Treatment for Opioid Use Disorder
    Davis, Corey S.
    Carr, Derek H.
    Glenn, Melody J.
    Samuels, Elizabeth A.
    ANNALS OF EMERGENCY MEDICINE, 2021, 78 (01) : 102 - 108
  • [34] Prescribers' satisfaction with delivering medications for opioid use disorder
    Knudsen, Hannah K.
    Brown, Randy
    Jacobson, Nora
    Horst, Julie
    Kim, Jee-Seon
    Kim, Hanna
    Madden, Lynn M.
    Haram, Eric
    Molfenter, Todd
    SUBSTANCE ABUSE TREATMENT PREVENTION AND POLICY, 2021, 16 (01)
  • [35] Racial Differences in Medications for Opioid Use Disorder Initiation in a Carceral Setting
    Berk, Justin
    Brar, Jessica
    Hoadley, Ariel
    Martin, Rosemarie
    SUBSTANCE USE & ADDICTION JOURNAL, 2025, 46 (01): : 64 - 71
  • [36] Engaging healthcare teams to increase access to medications for opioid use disorder
    Oberman, Rebecca S.
    Huynh, Alexis K.
    Cummings, Kelsey
    Resnick, Adam
    Taylor, Stephanie L.
    Bergman, Alicia A.
    Chang, Evelyn T.
    HEALTH SERVICES RESEARCH, 2024, 59
  • [37] The impact of the COVID-19 pandemic on medications for opioid use disorder services in the US and Canada: a scoping review
    Parker, Daniel G.
    Zentner, Daysi
    Burack, Jacob A.
    Wendt, Dennis C.
    DRUGS-EDUCATION PREVENTION AND POLICY, 2023, 30 (06) : 529 - 542
  • [38] Legislatively mandated implementation of medications for opioid use disorders in jails: A qualitative study of clinical, correctional, and jail administrator perspectives
    Pivovarova, Ekaterina
    Evans, Elizabeth A.
    Stopka, Thomas J.
    Santelices, Claudia
    Ferguson, Warren J.
    Friedmann, Peter D.
    DRUG AND ALCOHOL DEPENDENCE, 2022, 234
  • [39] Variation in Initiation, Engagement, and Retention on Medications for Opioid Use Disorder Based on Health Insurance Plan Design
    Morgan, Jake R.
    Quinn, Emily K.
    Chaisson, Christine E.
    Ciemins, Elizabeth
    Stempniewicz, Nikita
    White, Laura F.
    Linas, Benjamin P.
    Walley, Alexander Y.
    LaRochelle, Marc R.
    MEDICAL CARE, 2022, 60 (03) : 256 - 263
  • [40] Association between clinically recognized suicidality and subsequent initiation or continuation of medications for opioid use disorder
    Frost, Madeline C.
    Richards, Julie E.
    Blosnich, John R.
    Hawkins, Eric J.
    Tsui, Judith I.
    Edelman, Jennifer
    Williams, Emily C.
    DRUG AND ALCOHOL DEPENDENCE, 2022, 237